GlassScriptPhysician profile
Jonathan David Cotto-Rodriguez
NPI 1134754377
$3,055.05
in general payments reported to CMS, 2019-2025
15 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $1,431 · 2023: $122 · 2024: $258 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,239.16 | 2022 | |
| Abbvie INC. | $719.52 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $249.88 | 2023-2025 | Miebo, Xiidra |
| Allergan, INC. | $164.88 | 2021-2022 | |
| Alcon Vision LLC | $137.09 | 2025 | Clareon Panoptix Pro |
| Dompe US, INC. | $125.01 | 2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $124.99 | 2021 | |
| Rxsight INC | $77.66 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Oyster Point Pharma, INC. | $63.27 | 2022-2024 | Tyrvaya |
| Harrow Eye, LLC | $57.56 | 2024-2025 | Vevye |
| Tearlab Corp | $29.11 | 2022-2024 | Scoutpro Osmolarity System |
| Merz Pharmaceuticals, LLC | $23.87 | 2021 | |
| Sun Pharmaceutical Industries INC. | $15.95 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.19 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cotto-Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.